Twin Tree Management
TAK icon

Twin Tree Management’s Takeda Pharmaceutical TAK Stock Holding History

Twin Tree Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-59,900
Closed -$1.01M – 1764
2021
Q2 		$1.01M Buy
+59,900
New +$1.02M ﹤0.01% 1020

Other funds holding TAK

GAM
Groupama Asset Management Paris, France $6.85B AUM 43.37% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Twin Tree Management's TAK Position: Q2 2024 in Review

Twin Tree Management sold out of Takeda Pharmaceutical (TAK) in Q2 2024, closing a stake of 388 shares — an estimated $5.39K sold.

Twin Tree Management first reported a position in TAK in Q2 2020 and held it in 10 quarters. The position peaked at $6.72M in Q4 2020. 283 funds tracked by Wall St. Rank hold TAK as of Q2 2024.

  • Twin Tree Management reported no remaining Takeda Pharmaceutical position as of Q2 2024 after selling out during the quarter.
  • Twin Tree Management sold 388 Takeda Pharmaceutical shares in Q2 2024, an estimated $5.39K.
  • Twin Tree Management first reported a position in Takeda Pharmaceutical in Q2 2020 and held it in 10 quarters.
  • Twin Tree Management's Takeda Pharmaceutical position peaked at $6.72M in Q4 2020.
  • 283 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2024.

Based on Twin Tree Management's 13F filing for Q2 2024, filed 13 Aug 2024.